Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 1 completed trials

    Completion Rate
    100%(1/1)
    Active Trials
    1(50%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    No phase data available

    Trial Status & Enrollment

    Completion Rate

    100.0%

    1 of 1 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    1

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Active(1)
    Completed(1)

    Detailed Status

    Active, not recruiting1
    Completed1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    1
    Success Rate
    100.0%
    Most Advanced
    Phase 2/3

    Trials by Status

    active_not_recruiting150%
    completed150%

    Recent Activity

    1 active trials
    Showing 2 of 2
    active_not_recruiting

    Longitudinal Early-onset Alzheimer's Disease Study Protocol

    NCT03507257
    completed

    Alzheimer's Disease Neuroimaging Initiative 2

    NCT01231971

    Clinical Trials (2)

    Showing 2 of 2 trials
    NCT03507257

    Longitudinal Early-onset Alzheimer's Disease Study Protocol

    Active Not Recruiting
    NCT01231971

    Alzheimer's Disease Neuroimaging Initiative 2

    Completed

    All 2 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    2